What are the unique highlights of the COVID-19 vaccine- VLA2001 under trial? While different companies have taken vario...
Sinovac Biotech, based in China, has signed a letter of agreement with the Ecuadorian Ministry of Public Healt...
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and the Murdoch Children’s Research Institute...
CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...
The Health Sciences Authority (HSA) has granted an interim authorisation under the Pandemic Special Access Route (PSAR) ...
The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of ...
The Therapeutic Goods Administration (TGA) in Australia has provisionally approved the Moderna COVID-19 vaccine, SPIKEVA...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, has announced that it will expand its collaborat...
Researchers at AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMe...
Intradermal COVID-19 vaccination studies are emerging in a global effort to multiply available doses by harnessing skin ...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced that the Russian one-shot ...
What are your views on the ongoing threat being imposed by the COVID-19 variants across the globe? How can those be best...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a new 'Call for Proposals' to...
US-based Novavax, Inc. has announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV237...
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...
The coronavirus crisis which has enraged the world has also opened up debates around IP and public health. The gen...
US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...
